Stryker devices, including its Mako robot for total joint replacements, have been added in several ASCs over the last year.
While the company’s sales grew 11.5% for its med-surg and neurotechnology applications, they grew 10.5% for its orthopedic and spine applications.
Stryker now expects its organic net sales to grow 7.5% to 9% in 2024, according to a Jan. 30 news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
